<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04184349</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-19-0760</org_study_id>
    <nct_id>NCT04184349</nct_id>
  </id_info>
  <brief_title>Truncal Ultrasound Guided Regional Anesthesia for Implantation and Revision of Automatic Implantable Cardioverter Defibrillators (AICDs) and Pacemakers in Pediatric Patients</brief_title>
  <official_title>Truncal Ultrasound Guided Regional Anesthesia for Implantation and Revision of AICDs and Pacemakers in Pediatric Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy and safety of truncal blocks for
      pacemaker and Automatic Implantable Cardioverter Defibrillator implantation in children and
      to prospectively evaluate whether there is a decrease in amount of narcotic medications need
      and track complications.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2, 2019</start_date>
  <completion_date type="Anticipated">December 2, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>total narcotic dose in milligram morphine equivalents (MME) needed</measure>
    <time_frame>upto 48 hours after procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain as measured by the visual analog scale (VAS) pain score</measure>
    <time_frame>up to 1.5 hours post procedure in post anesthesia care unit (PACU)</time_frame>
    <description>VAS pain scale is a range of scores from 0-100. A higher score indicates greater pain intensity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with the incidence of pruritis</measure>
    <time_frame>upto 48 hours after procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with the incidence of nausea/vomiting</measure>
    <time_frame>upto 48 hours after procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with respiratory depression</measure>
    <time_frame>upto 48 hours after procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with local anesthetic toxicity</measure>
    <time_frame>upto 48 hours after procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with incidence of pneumothorax</measure>
    <time_frame>upto 48 hours after procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Analgesia After Pacemaker</condition>
  <condition>AICDS Implantation Pediatrics</condition>
  <arm_group>
    <arm_group_label>Local Anesthetic (LA Group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LA group</intervention_name>
    <description>In the LA group, only the local anesthetic infiltration will be performed by injecting the numbing medicine ropivacaine into the surgical site.</description>
    <arm_group_label>Local Anesthetic (LA Group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>B Group</intervention_name>
    <description>In the B Group,pectoral (PECS) and transversus thoracic plane(TTP) blocks will be performed by injecting the numbing medicine ropivacaine near the nerves.</description>
    <arm_group_label>B group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing implantation or revision of pacemaker or AICD in the pediatric
             cath lab

        Exclusion Criteria:

          -  parent or patient refusal

          -  use of narcotic medications prior to procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olga Pewelek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olga Pewelek, MD</last_name>
    <phone>7135006227</phone>
    <email>Olga.I.Lyuksyutova@uth.tmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Olga Pewelek, MD</last_name>
      <phone>713-500-6227</phone>
      <email>Olga.I.Lyuksyutova@uth.tmc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 7, 2019</study_first_submitted>
  <study_first_submitted_qc>December 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2019</study_first_posted>
  <last_update_submitted>December 2, 2019</last_update_submitted>
  <last_update_submitted_qc>December 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Olga Pawelek</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>pacemaker</keyword>
  <keyword>AICDS</keyword>
  <keyword>regional anesthesia</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

